Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1

Journal of Clinical Investigation

Volumn 119, Issue 1, 2009, Pages 99-109

  Eikermann Haerter, Katharina ^a,b   Dileköz, Ergin ^a   Kudo, Chiho ^a   Savitz, Sean I ^c   Waeber, Christian ^a   Baum, Michael J ^d   Ferrari, Michel D ^e   Van Den Maagdenberg, Arn M J M ^e   Moskowitz, Michael A ^a   Ayata, Cenk ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d Boston University   (United States)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VOLTAGE GATED CALCIUM CHANNEL; CACNA1A PROTEIN, HUMAN; CALCIUM CHANNEL; ESTROGEN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CACNA1A GENE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; EPILEPTIC AURA; ESTROGEN THERAPY; FAMILIAL HEMIPLEGIC MIGRAINE; FEMALE; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMIPARESIS; HEREDITY; LETHALITY; MALE; MOUSE; MUTANT; NERVE CELL; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROLOGIC DISEASE; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; SEX DIFFERENCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; ELECTROPHYSIOLOGY; EVOKED RESPONSE; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MIGRAINE WITH AURA; PARESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; SPREADING CORTICAL DEPRESSION; TRANSGENIC MOUSE;

ANIMALS; CALCIUM CHANNELS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; ESTROGENS; EVOKED POTENTIALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIGRAINE WITH AURA; OVARIECTOMY; PARESIS; PHENOTYPE; SPREADING CORTICAL DEPRESSION;

EID: 61749094194     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI36059     Document Type: Article

References (97)

1. Somjen, G.G. 2001. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev. 81:1065-1096.
2. Leao, A.A.P. 1944. Spreading depression of activity in cerebral cortex. J. Neurophysiol. 7:359-390.
3. Bolay, H., et al. 2002. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med. 8:136-142.
4. Ayata, C., Jin, H., Kudo, C., Dalkara, T., and Moskowitz, M.A. 2006. Suppression of cortical spreading depression in migraine prophylaxis. Ann. Neurol. 59:652-661.
5. Lauritzen, M. 1994. Pathophysiology of the migraine aura: the spreading depression theory. Brain. 117:199-210.
6. Hadjikhani, N., et al. 2001. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. U. S. A. 98:4687-4692.
7. Cao, Y., Welch, K.M., Aurora, S., and Vikingstad, E.M. 1999. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch. Neurol. 56:548-554.
8. International Headache Society. 2004. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 24(Suppl. 1):9-160.
9. Thomsen, L.L., et al. 2002. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain. 125:1379-1391.
10. van den Maagdenberg, A.M., Haan, J., Terwindt, G.M., and Ferrari, M.D. 2007. Migraine: gene mutations and functional consequences. Curr. Opin. Neurol. 20:299-305.
11. Pietrobon, D. 2005. Migraine: new molecular mechanisms. Neuroscientist. 11:373-386.
12. Ophoff, R.A., et al. 1996. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 87:543-552.
13. van den Maagdenberg, A.M., et al. 2004. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 41:701-710.
14. Tottene, A., et al. 2005. Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J. Biol. Chem. 280:17678-17686.
15. Kors, E.E., et al. 2001. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol. 49:753-760.
16. Tottene, A., et al. 2002. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. U. S. A. 99:13284-13289.
17. Pietrobon, D. 2007. Familial hemiplegic migraine. Neurotherapeutics. 4:274-284.
18. MacGregor, E.A. 2004. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 3:354-361.
19. Smith, S.S. 1989. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res. 503:354-357.
20. Sato, K., Matsuki, N., Ohno, Y., and Nakazawa, K. 2003. Estrogens inhibit l-glutamate uptake activity of astrocytes via membrane estrogen receptor alpha. J. Neurochem. 86:1498-1505.
21. Woolley, C.S., Weiland, N.G., McEwen, B.S., and Schwartzkroin, P.A. 1997. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 17:1848-1859.
22. Ertresvag, J.M., Zwart, J.A., Helde, G., Johnsen, H.J., and Bovim, G. 2005. Headache and transient focal neurological symptoms during pregnancy, a pro spective cohort. Acta Neurol. Scand. 111:233-237.
23. Granella, F., et al. 1993. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache. 33:385-389.
24. Nagel-Leiby, S., Welch, K.M., Grunfeld, S., and D'Andrea, G. 1990. Ovarian steroid levels in migraine with and without aura. Cephalalgia. 10:147-152.
25. Rasmussen, B.K., Jensen, R., Schroll, M., and Olesen, J. 1991. Epidemiology of headache in a general population - a prevalence study. J. Clin. Epidemiol. 44:1147-1157.
26. Bille, B.S. 1962. Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls. Acta Paediatr. Suppl. 136:1-151.
27. Eriksen, M.K., Thomsen, L.L., and Olesen, J. 2006. Implications of clinical subtypes of migraine with aura. Headache. 46:286-297.
28. Thomsen, L.L., et al. 2007. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain. 130:346-356.
29. Fifkova, E., and Bures, J. 1964. Spreading depression in the mammalian striatum. Arch. Int. Physiol. Biochim. 72:171-179.
30. Vinogradova, L.V., Koroleva, V.I., and Bures, J. 1991. Re-entry waves of Leao's spreading depression between neocortex and caudate nucleus. Brain Res. 538:161-164.
31. Kunkler, P.E., and Kraig, R.P. 2004. P/Q Ca2+ channel blockade stops spreading depression and related pyramidal neuronal Ca2+ rise in hippocampal organ culture. Hippocampus. 14:356-367.
32. Richter, F., Ebersberger, A., and Schaible, H.G. 2002. Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression. Neurosci. Lett. 334:123-126.
33. Ayata, C., Shimizu-Sasamata, M., Lo, E.H., Noebels, J.L., and Moskowitz, M.A. 2000. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels. Neuroscience. 95:639-645.
34. Marrannes, R., Willems, R., De Prins, E., and Wauquier, A. 1988. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 457:226-240.
35. Amemori, T., and Bures, J. 1990. Ketamine blockade of spreading depression: rapid development of tolerance. Brain Res. 519:351-354.
36. Jing, J., Aitken, P.G., and Somjen, G.G. 1991. Lasting neuron depression induced by high potassium and its prevention by low calcium and NMDA receptor blockade. Brain Res. 557:177-183.
37. Nellgard, B., and Wieloch, T. 1992. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol. Scand. 146:497-503.
38. McLachlan, R.S. 1992. Suppression of spreading depression of Leao in neocortex by an N-methyl-D-aspartate receptor antagonist. Can. J. Neurol. Sci. 19:487-491.
39. Kaja, S., et al. 2005. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience. 135:81-95.
40. Fettes, I. 1999. Migraine in the menopause. Neurology. 53:S29-S33.
41. Smith, M.J., Adams, L.F., Schmidt, P.J., Rubinow, D.R., and Wassermann, E.M. 2002. Effects of ovarian hormones on human cortical excitability. Ann. Neurol. 51:599-603.
42. Aegidius, K.L., Zwart, J.A., Hagen, K., Schei, B., and Stovner, L.J. 2007. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur. J. Neurol. 14:73-78.
43. MacGregor, A. 1999. Estrogen replacement and migraine aura. Headache. 39:674-678.
44. Kaiser, H.J., and Meienberg, O. 1993. Deterioration or onset of migraine under oestrogen replacement therapy in the menopause. J. Neurol. 240:195-196.
45. Klein, P., and Herzog, A.G. 1998. Hormonal effects on epilepsy in women. Epilepsia. 39(Suppl. 8):S9-S16.
46. Woolley, D.E., and Timiras, P.S. 1962. Estrous and circadian periodicity and electroshock convulsions in rats. Am. J. Physiol. 202:379-382.
47. Edwards, H.E., Burnham, W.M., Mendonca, A., Bowlby, D.A., and MacLusky, N.J. 1999. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res. 838:136-150.
48. Okamoto, K., Hirata, H., Takeshita, S., and Bereiter, D.A. 2003. Response properties of TMJ units in superficial laminae at the spinomedullary junction of female rats vary over the estrous cycle. J. Neurophysiol. 89:1467-1477.
49. Bereiter, D.A., Stanford, L.R., and Barker, D.J. 1980. Hormone-induced enlargement of receptive fields in trigeminal mechanoreceptive neurons. II. Possible mechanisms. Brain Res. 184:411-423.
50. Sood, S.V. 1971. Hemiplegic migraine associated with menstruation. J. Obstet. Gynaecol. Br. Commonw. 78:762-763.
51. Qiu, J., et al. 2006. Estrogen upregulates T-type calcium channels in the hypothalamus and pituitary. J. Neurosci. 26:11072-11082.
52. Sedej, S., Tsujimoto, T., Zorec, R., and Rupnik, M. 2004. Voltage-activated Ca(2+) channels and their role in the endocrine function of the pituitary gland in newborn and adult mice. J. Physiol. 555:769-782.
53. Ritchie, A.K. 1993. Estrogen increases low voltage-activated calcium current density in GH3 anterior pituitary cells. Endocrinology. 132:1621-1629.
54. Fiordelisio, T., Jimenez, N., Baba, S., Shiba, K., and Hernandez-Cruz, A. 2007. Immunoreactivity to neurofilaments in the rodent anterior pituitary is associated with the expression of alpha 1A protein subunits of voltage-gated Ca2+ channels. J. Neuroendocrinol. 19:870-881.
55. Chang, S.Y., et al. 2007. Age and gender-dependent alternative splicing of P/Q-type calcium channel EF-hand. Neuroscience. 145:1026-1036.
56. Brennan, K.C., Romero Reyes, M., Lopez Valdes, H.E., Arnold, A.P., and Charles, A.C. 2007. Reduced threshold for cortical spreading depression in female mice. Ann. Neurol. 61:603-606.
57. Weiss, T., and Fifkova, E. 1963. The effect of neocortical and caudatal spreading depression on "circling movements" induced from the caudate nucleus. Physiol. Bohemoslov. 12:332-338.
58. Trachtenberg, M.C., Hull, C.D., and Buchwald, N.A. 1970. Electrophysiological concomitants of spreading depression in caudate and thalamic nuclei of the cat. Brain Res. 20:219-231.
59. Jakobartl, L., and Huston, J.P. 1977. Circling and consumatory behavior induced by striatal and neocortical spreading depression. Physiol. Behav. 19:673-677.
60. DeLuca, B., Shibata, M., Brozek, G., and Bures, J. 1975. Facilitation of Leao's spreading depression by a pyrrolopyrimidine derivative. Neuropharmacology. 14:537-545.
61. Krivanek, J., and Fifkova, E. 1965. The value of ultramicro-analysis of lactic acid in tracing the penetration of Leao's cortical spreading depression to subcortical areas. J. Neurol. Sci. 2:385-392.
62. Fifkova, E., and Syka, J. 1964. Relationships between cortical and striatal spreading depression in rat. Exp. Neurol. 9:355-366.
63. Piper, R.D., and Lambert, G.A. 1996. Inhalational anesthetics inhibit spreading depression: relevance to migraine. Cephalalgia. 16:87-92.
64. Kitahara, Y., Taga, K., Abe, H., and Shimoji, K. 2001. The effects of anesthetics on cortical spreading depression elicitation and c-fos expression in rats. J. Neurosurg. Anesthesiol. 13:26-32.
65. Ayata, C., et al. 2004. Pronounced hypoperfusion during spreading depression in mouse cortex. J. Cereb. Blood Flow Metab. 24:1172-1182.
66. Takano, T., et al. 2007. Cortical spreading depression causes and coincides with tissue hypoxia. Nat. Neurosci. 10:754-762.
67. Berger, M., Speckmann, E.J., Pape, H.C., and Gorji, A. 2008. Spreading depression enhances human neocortical excitability in vitro. Cephalalgia. 28:558-562.
68. Footitt, D.R., and Newberry, N.R. 1998. Cortical spreading depression induces an LTP-like effect in rat neocortex in vitro. Brain Res. 781:339-342.
69. Gorji, A., and Speckmann, E.J. 2004. Spreading depression enhances the spontaneous epileptiform activity in human neocortical tissues. Eur. J. Neurosci. 19:3371-3374.
70. Gorji, A., Zahn, P.K., Pogatzki, E.M., and Speckmann, E.J. 2004. Spinal and cortical spreading depression enhance spinal cord activity. Neurobiol. Dis. 15:70-79.
71. Ducros, A., et al. 2001. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 345:17-24.
72. Ducros, A., et al. 1997. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann. Neurol. 42:885-890.
73. Echenne, B., et al. 1999. Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics. 30:214-217.
74. Kramer, U., Lerman-Sagi, T., Margalith, D., and Harel, S. 1997. A family with hemiplegic migraine and focal seizures. Eur. J. Paediatr. Neurol. 1:35-38.
75. Cevoli, S., et al. 2002. Familial hemiplegic migraine: clinical features and probable linkage to chromosome 1 in an Italian family. Neurol. Sci. 23:7-10.
76. Jurkat-Rott, K., et al. 2004. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology. 62:1857-1861.
77. Terwindt, G.M., et al. 1997. Partial cosegregation of familial hemiplegic migraine and a benign familial infantile epileptic syndrome. Epilepsia. 38:915-921.
78. Deprez, L., et al. 2008. Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia. 49:500-508.
79. Jouvenceau, A., et al. 2001. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet. 358:801-807.
80. Beauvais, K., et al. 2004. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur. Neurol. 52:58-61.
81. Vahedi, K., et al. 2000. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology. 55:1040-1042.
82. Kors, E.E., et al. 2003. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch. Neurol. 60:684-688.
83. Curtain, R.P., Smith, R.L., Ovcaric, M., and Griffiths, L.R. 2006. Minor head trauma-induced sporadic hemiplegic migraine coma. Pediatr. Neurol. 34:329-332.
84. Lakso, M., et al. 1996. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. U. S. A. 93:5860-5865.
85. Nomura, M., McKenna, E., Korach, K.S., Pfaff, D.W., and Ogawa, S. 2002. Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res. Mol. Brain Res. 109:84-94.
86. Sullivan, T.R., Jr., et al. 1995. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J. Clin. Invest. 96:2482-2488.
87. Bergman, M.D., et al. 1992. Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiol. Endocrinology. 130:1923-1930.
88. Horsburgh, K., Macrae, I.M., and Carswell, H. 2002. Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J. Cereb. Blood Flow Metab. 22:1189-1195.
89. Becker, J.B., et al. 2005. Strategies and methods for research on sex differences in brain and behavior. Endocrinology. 146:1650-1673.
90. Felicio, L.S., Nelson, J.F., and Finch, C.E. 1980. Spontaneous pituitary tumorigenesis and plasma oestradiol in ageing female C57BL/6J mice. Exp. Gerontol. 15:139-143.
91. Sherman, B.M., West, J.H., and Korenman, S.G. 1976. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metab. 42:629-636.
92. Nelson, J.F., Felicio, L.S., Osterburg, H.H., and Finch, C.E. 1981. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol. Reprod. 24:784-794.
93. Belisle, S., and Lehoux, J.G. 1983. Endocrine aging in C57 BL mice - II. Dynamics of estrogen receptors in the hypothalamic-pituitary axis. J. Steroid Biochem. 18:737-743.
94. Belisle, S., Bellabarba, D., and Lehoux, J.G. 1985. Age-dependent, ovary-independent decrease in the nuclear binding kinetics of estrogen receptors in the brain of the C57BL/6J mouse. Am. J. Obstet. Gynecol. 153:394-401.
95. Strathy, J.H., Coulam, C.B., and Spelsberg, T.C. 1982. Comparison of estrogen receptors in human premenopausal and postmenopausal uteri: indication of biologically inactive receptor in postmenopausal uteri. Am. J. Obstet. Gynecol. 142:372-382.
96. Tureyen, K., et al. 2007. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 101:41-56.
97. Beckman, J.S., Parks, D.A., Pearson, J.D., Marshall, P.A., and Freeman, B.A. 1989. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic. Biol. Med. 6:607-615.